Titel

Merkliste
1 Ergebnisse

Daratumumab, bortezomib, and dexamethasone in relapsed or r..:

Weisel, K ; Spencer, A ; Lentzsch, S...
Weisel , K , Spencer , A , Lentzsch , S , Avet-Loiseau , H , Mark , T M , Spicka , I , Masszi , T , Lauri , B , Levin , M-D , Bosi , A , Hungria , V , Cavo , M , Lee , JJ , Nooka , A , Quach , H , Munder , M , Lee , C , Barreto , W , Corradini , P , Min , CK , Chanan-Khan , AA , Horvath , N , Capra , M , Beksac , M , Ovilla , R , Jo , J C , Shin , HJ , Sonneveld , P , Casneuf , T , Deangelis , N , Amin , H , Ukropec , J , Kobos , R & Mateos , MV 2020 , ' Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: Subgroup analysis of CASTOR based on cytogenetic risk ' , Journal of Hematology and Oncology , vol. 13 , no. 1 , 115 . https://doi.org/10.1186/s13045-020-00948-5. , 2020

Link: https://pure.eur.nl/en/publications/4a3ae139-d91b-4ec7..

RT Journal
T1 <Title>Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: Subgroup analysis of CASTOR based on cytogenetic risk</Title>

UL https://suche.suub.uni-bremen.de/peid=base-fturottercrispub:oai:pure.eur.nl:publications_4a3ae139-d91b-4ec7-aede-2cccbadac76d&Exemplar=1&LAN=DE
				
A1 Weisel, K
A1 Spencer, A
A1 Lentzsch, S
A1 Avet-Loiseau, H
A1 Mark, T M
A1 Spicka, I
A1 Masszi, T
A1 Lauri, B
A1 Levin, Mark-David
A1 Bosi, A
A1 Hungria, V
A1 Cavo, M
A1 Lee, JJ
A1 Nooka, A
A1 Quach, H
A1 Munder, M
A1 Lee, C
A1 Barreto, W
A1 Corradini, P
A1 Min, CK
A1 Chanan-Khan, AA
A1 Horvath, N
A1 Capra, M
A1 Beksac, M
A1 Ovilla, R
A1 Jo, J C
A1 Shin, HJ
A1 Sonneveld, Pieter
A1 Casneuf, T
A1 Deangelis, N
A1 Amin, H
A1 Ukropec, J
A1 Kobos, R
A1 Mateos, MV
YR 2020
JF Weisel , K , Spencer , A , Lentzsch , S , Avet-Loiseau , H , Mark , T M , Spicka , I , Masszi , T , Lauri , B , Levin , M-D , Bosi , A , Hungria , V , Cavo , M , Lee , JJ , Nooka , A , Quach , H , Munder , M , Lee , C , Barreto , W , Corradini , P , Min , CK , Chanan-Khan , AA , Horvath , N , Capra , M , Beksac , M , Ovilla , R , Jo , J C , Shin , HJ , Sonneveld , P , Casneuf , T , Deangelis , N , Amin , H , Ukropec , J , Kobos , R & Mateos , MV 2020 , ' Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: Subgroup analysis of CASTOR based on cytogenetic risk ' , Journal of Hematology and Oncology , vol. 13 , no. 1 , 115 . https://doi.org/10.1186/s13045-020-00948-5
LK http://dx.doi.org/https://pure.eur.nl/en/publications/4a3ae139-d91b-4ec7-aede-2cccbadac76d
DO https://pure.eur.nl/en/publications/4a3ae139-d91b-4ec7-aede-2cccbadac76d
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)